Home/Filings/4/0001437749-25-005873
4//SEC Filing

Disbrow Joshua R. 4

Accession 0001437749-25-005873

CIK 0001385818other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 1:35 PM ET

Size

5.3 KB

Accession

0001437749-25-005873

Insider Transaction Report

Form 4
Period: 2025-02-28
Disbrow Joshua R.
Chief Executive Officer
Transactions
  • Purchase

    Common Stock

    2025-02-28$1.30/sh+15,000$19,50086,591 total
Footnotes (1)
  • [F1]On February 28, 2025, Joshua R. Disbrow, purchased a total of 15,000 shares of common stock in multiple open market transaction at prices per share ranging from $1.29 to $1.30, with a weighted average price of approximately $1.30 per share. Mr. Disbrow undertakes to provide to AYTU BIOPHARMA, INC., any security holder of AYTU BIOPHARMA, INC., or the staff of the United States Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Issuer

AYTU BIOPHARMA, INC

CIK 0001385818

Entity typeother

Related Parties

1
  • filerCIK 0001566240

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 1:35 PM ET
Size
5.3 KB